Latest Breaking News On - Continuous renal replacement therapy - Page 1 : comparemela.com

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, announces that eight.

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

Study demonstrated safety and tolerability of H-Guard®, a second generation complement regulator, designed to address serious immune system-driven complications of dialysis.Encouraging biomarker data positions H-Guard for upcoming Acute Kidney Injury (AKI) trial focused on reducing complement mediated renal tubu.

Doggie Dialysis: DoveLewis saves two dogs from potential overdose

Dialysis Saves Dogs From Overdose | 106.7 The Eagle

DoveLewis dialysis machine saves two dogs that accidentally overdosed on pain medication.

Dialysis Saves Dogs From Overdose | Z100 Portland

DoveLewis dialysis machine saves two dogs that accidentally overdosed on pain medication.